School of Medicine


Showing 101-200 of 309 Results

  • Catherine Benedict

    Catherine Benedict

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests My research focuses on improving cancer survivorship through better understanding of long-term health outcomes and through the development of theoretically driven, evidence-based behavioral interventions to improve adjustment, risk management, and quality of life. To this end, I lead studies aimed to guide and support patient decision-making and self-management after cancer. Much of my work focuses on the experiences of young adults affected by cancer.

  • Ori-Michael Johanan Benhamou

    Ori-Michael Johanan Benhamou

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Benhamou received his Bachelor's degree at Duke University and went on to complete medical school at Ben-Gurion University. He completed his residency in Psychiatry at Westchester Medical Center and fellowship in Addiction Medicine at Stanford. He has published works in the areas of suicide, autoimmune encephalitis and addiction. His current interests include substance abuse, the role of transcranial magnetic stimulation on addiction and the intersection of suicide and substance abuse.

  • William Benitz

    William Benitz

    Philip Sunshine, M.D., Professor in Neonatology, Emeritus

    Current Research and Scholarly Interests Neonatology, patent ductus arteriosus, pulmonary hypertension of the newborn, infant ventilation, neonatal clinical protocols/clinical pathways.

  • Christopher Bennett

    Christopher Bennett

    Clinical Instructor, Emergency Medicine

    Bio Christopher Bennett M.D. M.A. is a physician scientist in the Department of Emergency Medicine at Stanford University. He completed residency training at Harvard Medical School's program in Emergency Medicine based at Massachusetts General Hospital. Christopher previously served on the 2018-2019 Board of Directors for the Society for Academic Emergency Medicine. He also served on the Massachusetts Medical Society's 2019-2020 Committee on Publications which directs the publication and distribution of the New England Journal of Medicine. Bennett graduated with honors from Winthrop University (B.S. in Biology), earned a graduate degree from Duke University (M.A. in Genetics and Genomics), and was awarded his medical degree (M.D.) from The University of North Carolina at Chapel Hill, School of Medicine. In addition to his formal graduate training, Bennett was previously a scientist with the Lineberger Comprehensive Cancer Center, a Howard Hughes Medical Institute Fellow at Johns Hopkins?s McKusick-Nathans Institute of Genetic Medicine, and a researcher with the Emergency Medicine Network based at Harvard and Massachusetts General Hospital. His research has appeared in journals such as the New England Journal of Medicine, JAMA Surgery, the Journal of Graduate Medical Education, Nature Genetics, Annals of Emergency Medicine, Academic Emergency Medicine. His writing has appeared in The American Journal of Bioethics, STAT News, KevinMD.com, and Forbes.

  • Rachel Bensen

    Rachel Bensen

    Clinical Assistant Professor, Pediatrics - Gastroenterology

    Current Research and Scholarly Interests My research focuses on improving health care delivery systems for children, adolescents and young adults with chronic illness and their families. I have particular interests in the development of chronic disease self-management skills, assessment of patient reported outcomes, the transition from pediatric to adult-oriented health care, and comprehensive programs to support families caring for a child with chronic illness.

  • Brandon S. Bentzley, MD, PhD

    Brandon S. Bentzley, MD, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Bentzley received his bachelors in physics from The College of New Jersey. Upon graduating he spent a year conducting plasma physics research in a joint project between Princeton University and NASA. Brandon then turned his interests to neuroscience and began his training in the Medical Scientist Training Program (MD/PhD) at the Medical University of South Carolina (MUSC). At MUSC Brandon completed his dissertation research with Gary Aston-Jones, PhD, studying the behavioral economics and neuroeconomics of substance use disorders. Simultaneously, he conducted clinical research on buprenorphine maintenance therapy, focusing on how patient perspectives influence treatment. Dr. Bentzley is now a psychiatrist and Clinical Assistant Professor in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. His current research interests focus on the role of dopamine in economic decisions and developing neurostimulation-based treatments for severe depression and suicidality.

  • Jonathan S. Berek, MD, MMS

    Jonathan S. Berek, MD, MMS

    Laurie Kraus Lacob Professor

    Bio Laurie Kraus Lacob Professor
    Stanford University School of Medicine

    Director, Stanford Women?s Cancer Center
    Senior Advisor, Stanford Cancer Institute

    Director, Stanford Health Communication Initiative
    Advancing Communication Excellence at Stanford
    Stanford Center for Health Education
    Office of the Vice Provost for Teaching and Learning
    Stanford University

    Director, Stanford Health Care Communication Program
    Stanford Health Care

  • Marc Berg

    Marc Berg

    Clinical Professor, Pediatrics - Critical Care

    Bio Dr. Berg was born and raised in rural Minnesota and has been in academic medicine since 1997. His research interests include CPR performance, pediatric defibrillation science, and education primarily through simulation. He has been a volunteer with the American Heart Association for more than 10 years, leading the Pediatric CPR course (PALS) in 2010. He has served in several administrative positions including Division Chief of Pediatric Critical Care at the University of Arizona, Board Director of the University of Arizona Health Network and Governor-appointed member of the Arizona Medical Board. In his free time he enjoys biking, reading and spending time with his family. He is married with three children and lives in Menlo Park, California.

    See his LinkedIn profile here:

    https://www.linkedin.com/in/marc-berg-6399934/

  • Ardin S. Berger (they/them)

    Ardin S. Berger (they/them)

    Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

    Bio Dr. Berger is a pediatric pain physician who is ABA boarded in pain medicine, anesthesiology, and pediatric anesthesiology.

  • David Bergman

    David Bergman

    Associate Professor of Pediatrics (General Pediatrics) at the Lucile Salter Packard Children's Hospital, Emeritus

    Current Research and Scholarly Interests My research has involved the use of new technologies to create different types of patient-doctor transactions. I am also interested in how these new transactions impact clinical care processes. Current work includes the evaluation of a patient portal for children with cystic fibrosis, the use of telemedicine to bring asthma experts into the schools and the attitudes of teens and parents about the use of a secure patient portal for teens.

  • Dominique Bergmann

    Dominique Bergmann

    Shirley R. and Leonard W. Ely, Jr. Professor of the School of Humanities and Sciences

    Current Research and Scholarly Interests We use genetic, genomic and cell biological approaches to study cell fate acquisition, focusing on cases where cell fate is correlated with asymmetric cell division.

  • John Randol Bergquist

    John Randol Bergquist

    Clinical Scholar, Surgery - General Surgery

    Current Research and Scholarly Interests Dr. Bergquist's research interests are driven by his clinical practice and his background as an engineer. Clinical research interests are focused on improving outcomes for cancer patients. Dr. Bergquist has published on the utilization of biomarkers in particular CA 19-9 as a means to appropriately triage the multidisciplinary management of patients with advanced GI cancers. In addition, he is interested in improving understanding of optimal surgical management through the utilization of big data to understand trends in treatment and incidence as well as genomic patterns in cancer. Dr. Bergquist is also interested in surgical education and has been active in the production of educational videos focused on technical aspects of HPB surgery and in particular minimally invasive techniques. Finally, Dr. Bergquist's background as an engineer drives him to focus on the intersection between technology and clinical care. To this end, he is passionate about innovation in both hardware and software, and the potential impact of innovative design on the field of medicine.

  • Michele Berk

    Michele Berk

    Assistant Professor of Psychiatry and Behavior Sciences (Child and Adolescent Psychiatry and Child Development) at the Stanford University Medical Center

    Current Research and Scholarly Interests The focus of my research is on adolescent suicidal and self-harm behavior. I am currently one of four Principal Investigators of a multisite NIMH-sponsored RCT of DBT for adolescents at high risk for suicide (NCT01528020: Collaborative Adolescent Research on Emotions and Suicide [CARES], PI: Linehan, McCauley, Berk, & Asarnow) aimed at evaluating the efficacy of DBT with adolescents compared to a combined individual and group supportive therapy control condition (IGST).

  • Rebecca Bernert

    Rebecca Bernert

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    Bio Dr. Bernert is Founding Director of the Suicide Prevention Research Laboratory, and Co-Chairs a special departmental initiative to develop a Center for Premature Mortality and Suicide Prevention. She is a suicidologist, with subspecialty expertise in suicide prevention clinical trials, standardized suicide risk assessment and best practice management, and the epidemiology of self-directed violence. She has subspecialty training in behavioral sleep medicine, with a background in sleep and circadian physiology. Her program utilizes cognitive, biologic (e.g., fMRI), and behavioral testing paradigms, with an emphasis on translational therapeutics. Dr. Bernert has collaborated with NIH, DOD, DARPA, SAMHSA, and CDC on suicide prevention initiatives; and recently served as a content expert for the White House 2015 Open Data and Innovation for Suicide Prevention #Hackathon. She has also contributed to the development of clinical practice parameters, including the 2013 VA/DOD Clinical Practice Guidelines for the Assessment and Management of Suicide Risk, with current work underway focused on investigating medical education training in suicide risk assessment and management. Her research focuses on the identification of novel therapeutic targets for suicide prevention across the lifespan, particularly those aiming to reduce stigma and enhance access to care. A specific focus of this work emphasizes the use of rapid-action, low-risk treatment approaches for the prevention of suicide. Dr. Bernert has several suicide prevention trials underway, funded by NIH and DOD, testing the preliminary efficacy of a non pharmacological insomnia treatment on suicidal behaviors. She also has several grants focused on the development of a data monitoring system for the study of local suicide clusters and emergency department based protocols to improve risk detection within pediatric suicide prevention. Our aim is to delineate transdiagnostic risk factors and biomarkers of clinical response that may inform the pathogenesis of risk and treatment innovation. An overarching mission is to harness new technologies within suicide prevention, including artificial intelligence (AI) and mobile health applications, to enhance risk detection and multidisciplinary frameworks. Advisory and advocacy work, and the way in which research guides health policy, dissemination, and national strategies for suicide prevention, represents an extension of this work. This includes recent initiatives to establish national and local guidelines for lethal means restriction and calls for advanced technology use in suicide prevention research and strategy. Last, Dr. Bernert has several pilot projects underway focused on inclusive practices in faculty diversity and development, and the way in which family-friendly policies impact faculty recruitment and retention in academic medicine.

  • Daniel Bernstein

    Daniel Bernstein

    Alfred Woodley Salter and Mabel Smith Salter Endowed Professor in Pediatrics

    Current Research and Scholarly Interests 1. Using iPSC-derived cardiomyocytes to understand hypertrophic cardiomyopathy and heart failure associated with congenital heart disease.
    2. Role of alterations in mitochondrial dycamics and function in normal physiology and disease.
    3. Differences between R and L ventricular responses to stress,
    4. Immune biomarkers of risk after pediatric VAD implantation.
    5. Biomarkers for post-transplant lymphoproliferative disorder.

  • Jon Bernstein

    Jon Bernstein

    Professor of Pediatrics (Genetics) at the Lucile Salter Packard Children's Hospital and, by courtesy, of Genetics

    Current Research and Scholarly Interests My research is focused on the diagnosis, discovery and delineation of rare genetic conditions with a focus of neurodevelopmental disorders. This work includes the application of novel computational methods and multi-omics profiling (whole genome sequencing, RNA sequencing, metabolomics). I additionally participate in an interdisciplinary project to develop induced pluripotent stem cell (iPSC) models of genetic neurodevelopmental disorders..

  • William Berquist

    William Berquist

    Professor of Pediatrics (Gastroenterology) at the Lucile Salter Packard Children's Hospital

    Current Research and Scholarly Interests Gastroenterology, gastointestinal motility, clinical management of pediatric liver transplant recipients.

  • Gerald Berry

    Gerald Berry

    Professor of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests Cardiopulmonary and pulmonary transplant medicine; diagnostic surgical pathology

  • Mark Berry, MD

    Mark Berry, MD

    Mylavarapu Rogers Professor of Cardiothoracic Surgery

    Bio Dr. Berry joined the Division of Thoracic Surgery at Stanford in August 2014. He came to Stanford from Duke University, where he had most recently served as Associate Professor. He received his medical degree at the University of Pennsylvania School of Medicine after receiving bachelors and masters degrees in Electrical Engineering at the University of Pennsylvania. He completed his residency in Cardiothoracic Surgery at Duke University Medical Center after performing a residency in General Surgery at the Hospital of the University of Pennsylvania. His Cardiothoracic Surgical training included a year dedicated to Minimally Invasive General Thoracic Surgery, a period that also included an American Association for Thoracic Surgery sponsored Traveling Fellowship at the University of Pittsburgh.

    Dr. Berry practices all aspects of thoracic surgery, including procedures for benign and malignant conditions of the lung, esophagus, and mediastinum. He has a particular interest in minimally invasive techniques, and has extensive experience in treating thoracic surgical conditions using video-assisted thoracoscopic surgical (VATS), laparoscopic, robotic, endoscopic, and bronchoscopic approaches. He serves as the co-Director of the Stanford Minimally Invasive Thoracic Surgery Center (SMITS), and has both directed and taught in several minimally invasive thoracic surgery courses.

    Dr. Berry also has a Masters of Health Sciences in Clinical Research from Duke University. His clinical research activities mirror his clinical interests and activities in optimizing short-term and long-term outcomes of patients with thoracic surgical conditions. He has more than sixty peer-reviewed publications, most of which are related to both the use of minimally invasive thoracic surgical techniques as well as evaluating outcomes after treatment of thoracic malignancies. His clinical practice and his research both focus on choosing the most appropriate treatment and approach for patients based on the individual characteristics of the patient and their disease process.

  • Edward Bertaccini

    Edward Bertaccini

    Professor of Anesthesiology, Perioperative and Pain Medicine at the Palo Alto Veterans Affairs Health Care System

    Current Research and Scholarly Interests molecular modeling of anesthetic-protein interactions, molecular modeling of the ligand-gated ion channels

  • Alice Bertaina MD, PhD

    Alice Bertaina MD, PhD

    Associate Professor of Pediatrics (Stem Cell Transplantation) at the Lucile Salter Packard Children's Hospital

    Current Research and Scholarly Interests Dr. Bertaina is a highly experienced clinician and will play a key role in supporting Section Chief Dr. Rajni Agarwal and Clinical Staff in the Stem Cell Transplant Unit at Lucile Packard Children?s Hospital. She will also continue her research on immune recovery and miRNA, understanding the mechanisms underlying immune reconstitution, Graft-versus-Host Disease (GvHD), and leukemia relapse after allogeneic HSCT in pediatric patients affected by hematological malignant and non-malignant disorders.

  • Carolyn Bertozzi

    Carolyn Bertozzi

    Baker Family Director of Stanford ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology

    Bio Professor Carolyn Bertozzi's research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface sugars important to human health and disease. Her research group profiles changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and uses this information to develop new diagnostic and therapeutic approaches, most recently in the area of immuno-oncology.

    Dr. Bertozzi completed her undergraduate degree in Chemistry at Harvard University and her Ph.D. at UC Berkeley, focusing on the chemical synthesis of oligosaccharide analogs. During postdoctoral work at UC San Francisco, she studied the activity of endothelial oligosaccharides in promoting cell adhesion at sites of inflammation. She joined the UC Berkeley faculty in 1996. A Howard Hughes Medical Institute Investigator since 2000, she came to Stanford University in June 2015, among the first faculty to join the interdisciplinary institute ChEM-H (Chemistry, Engineering & Medicine for Human Health). She is now the Baker Family Director of Stanford ChEM-H.

    Named a MacArthur Fellow in 1999, Dr. Bertozzi has received many awards for her dedication to chemistry, and to training a new generation of scientists fluent in both chemistry and biology. She has been elected to the Institute of Medicine, National Academy of Sciences, and American Academy of Arts and Sciences; and received the Lemelson-MIT Prize, the Heinrich Wieland Prize, the ACS Award in Pure Chemistry, and the Chemistry of the Future Solvay Prize, among others.

    The Bertozzi Group develops chemical tools to study the glycobiology underlying diseases such as cancer, inflammation, tuberculosis and most recently COVID-19. She is the inventor of "bioorthogonal chemistry", a class of chemical reactions compatible with living systems that enable molecular imaging and drug targeting. Her group also developed new therapeutic modalities for targeted degradation of extracellular biomolecules, such as antibody-enzyme conjugates and Lysosome Targeting Chimeras (LYTACs). As well, her group studies NGly1 deficiency, a rare genetic disease characterized by loss of the human N-glycanase.

    Several of the technologies developed in the Bertozzi lab have been adapted for commercial use. Actively engaged with several biotechnology start-ups, Dr. Bertozzi cofounded Redwood Bioscience, Enable Biosciences, Palleon Pharmaceuticals, InterVenn Bio, OliLux Bio, Grace Science LLC and Lycia Therapeutics. She is also a member of the Board of Directors of Lilly.

  • Jill Beyer, OD

    Jill Beyer, OD

    Clinical Assistant Professor, Ophthalmology

    Bio Jill Beyer, OD, is a Clinical Assistant Professor at Stanford University School of Medicine.

    Dr. Beyer graduated from Southern California College of Optometry, earning her Doctor of Optometry degree with distinction. She completed her residency at New England College of Optometry in Boston, Massachusetts, and earned a Bachelor of Science degree in Biology from Oregon State University.

    Jill?s residency education included time spent at the Boston Foundation for Sight, Massachusetts Eye and Ear Infirmary, Cornea Consultants & Boston Laser Center, and Harvard Vanguard Medical Associates.

    After residency training, Jill continued on as a clinical preceptor at the New England College of Optometry while working in private practice in Boston. She then transitioned to full time academic work at the Massachusetts Eye and Ear Infirmary becoming the Director of the Contact Lens Department and an Instructor in Ophthalmology at Harvard Medical School.

  • Vivek Bhalla, MD

    Vivek Bhalla, MD

    Associate Professor of Medicine (Nephrology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.

  • Rashmi Parekh Bhandari

    Rashmi Parekh Bhandari

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly Interests Clinical interventions, treatments, and outcomes in pediatric pain management

  • Ankur Bharija

    Ankur Bharija

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly Interests Personal and Professional (Clinical, research, and teaching) interests include promoting health and wellbeing for the frail elders and the seriously ill -- through innovation in High-value healthcare delivery systems, Public health-education, Health Information-technology and Social entrepreneurship.

  • Mahendra Bhati

    Mahendra Bhati

    Clinical Professor, Psychiatry and Behavioral Sciences

    Bio Dr. Bhati is a board certified neuropsychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia and was a principle investigator for the DSM-5 academic field trials. His research experience included roles as an investigator in the first controlled clinical trials of deep brain stimulation and low field synchronized TMS for treatment of depression. His current interests include studying TMS-evoked potentials as biomarkers for neuropsychiatric disorders, augmented-reality TMS, closed-loop responsive neurostimulation for treatment of impulse and fear-related disorders, and magnetic resonance guided focused ultrasound for treatment-resistant obsessive compulsive disorder and depression.

  • Ami Bhatt

    Ami Bhatt

    Assistant Professor of Medicine (Hematology) and of Genetics

    Current Research and Scholarly Interests The Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.

  • Jayanta Bhattacharya

    Jayanta Bhattacharya

    Professor of Medicine, Senior Fellow at the Stanford Institute for Economic Policy Research and Professor, by courtesy, of Economics

    Current Research and Scholarly Interests My research focuses on the constraints that vulnerable populations face in making decisions that affect their health status, as well as the effects of government policies and programs designed to benefit vulnerable populations.

  • Nidhi Bhutani

    Nidhi Bhutani

    Associate Professor of Orthopaedic Surgery

    Current Research and Scholarly Interests The long-term goal of our research is to understand the fundamental mechanisms that govern and reprogram cellular fate during development, regeneration and disease.

  • Vinod (Vinny) K. Bhutani

    Vinod (Vinny) K. Bhutani

    Professor of Pediatrics (Neonatology) at the Lucile Salter Packard Children's Hospital, Emeritus

    Current Research and Scholarly Interests Neonatology; newborn jaundice, bilirubin biology and kernicterus prevention; pulmonary physiology, pulmonary functions and neonatal ventilation. To promote newborn screening for G6PD deficiency in USA.

  • Y. Katherine Bianco

    Y. Katherine Bianco

    Clinical Associate Professor, Obstetrics & Gynecology - Maternal Fetal Medicine

    Bio My clinical interest in pregnancies complicated with birth defects has led my underlying research interests in genomic abnormalities in the human trophoblast carrying to faulty placentation. The latter began with initial work during K12 and KO8 funding. I took a great interest in the human placenta as it carries potential advantages over other tissues sources: first, this highly metabolically active organ is the potential source of many transcripts. Second, the placenta forms at a very early stage of embryonic development, potentially allowing detection of primary alterations as compared to secondary changes that may mask the underlying causal phenomena. Finally, studying early placentation may provide targets for development of novel molecular approaches, such as up-regulate or down-regulate genes, the protein products of which could potentially serve as molecular surrogates for diagnosis and treatment of pregnancy complication such as miscarriages, pre-eclampsia, pregnancy induced hypertension and intrauterine growth retardation. This work has led to the first Trisomy 21, Trisomy 18, trisomy 13 cell lines established from human placentas making it possible to apply gene editing in the early stages of human trophoblast development.

    As my primary clinical responsibility involves treating patients needing medical care and support through their high risk pregnancies, I am interested in factors that may impact outcomes, such as prenatal screening and diagnosis, maternal heart conditions, labor and delivery management, and safety approaches for the second stage of labor. In investigating length of labor and approaches to shorten the second stage, I have found methods of improving perinatal outcomes in diverse maternal populations.

    With regards to my interest in fetal medicine, I have worked in collaboration with other specialists such as radiologists and pediatric cardiologists utilizing imagining studies to assess and determine successful perinatal care and fetal survival.

  • David Bingham

    David Bingham

    Clinical Assistant Professor, Pathology

    Bio David Bingham MD is a clinical assistant pathologist specializing in gastrointestinal pathology. He is from Connecticut, graduated from Yale with a BA, and went to Columbia P&S for medical school. He did a residency in Pathology at Stanford University, graduated in 1992 and has been here ever since as a faculty member.

  • Julius Bishop, MD

    Julius Bishop, MD

    Associate Professor of Orthopaedic Surgery at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Bishop specializes in treating fractures of the upper extremity, lower extremity, pelvis and acetabulum as well as the management of post-traumatic problems including malunion, nonunion and infection.

    He received his undergraduate and medical school degrees from Harvard University and went on to complete the Harvard Combined Orthopaedic Surgery Residency Program. He pursued his subspecialty training in Orthopaedic Traumatology at the world-renowned Harborview Medical Center in Seattle, Washington.

    His research interests include applying decision analysis models to orthopaedic trauma problems, studying clinical outcomes after musculoskeletal injury, orthopaedic biomechanics, the basic science of fracture healing, and evaluating new strategies and techniques in fracture surgery.

  • Sandip Biswal, MD

    Sandip Biswal, MD

    Associate Professor of Radiology (Musculoskeletal Imaging) at the Stanford University Medical Center

    Current Research and Scholarly Interests The management of individuals suffering from chronic pain is unfortunately limited by poor diagnostic tests and therapies. Our research group is interested in 'imaging pain' by using novel imaging techniques to study peripheral nociception and inflammation with the goal of accurately identifying the location of pain generators. We are developing new approaches with positron emission tomography (PET) and magnetic resonance imaging (MRI) (PET/MRI) and are currently in clinical trials.

  • Brian Blackburn

    Brian Blackburn

    Clinical Associate Professor, Medicine - Infectious Diseases

    Current Research and Scholarly Interests My interests include parasitology and global health; I've investigated cryptosporidium and angiostrongylus outbreaks; schistosoma/strongyloides seroprevalence in refugees, and the distribution and impact of ITNs for malaria and filariasis prevention in Nigeria and India. I have done clinical and programmatic work at teaching hospitals in Liberia and Bangladesh and have opportunities for research in Bangladesh and Kenya, in collaboration with ICDDR,B and CDC, Kenya

  • Richard Bland

    Richard Bland

    Professor (Research) of Pediatrics (Neonatology), Emeritus

    Current Research and Scholarly Interests Our research focuses on the pathogenesis and treatment of acute and chronic neonatal lung injury and the mechanisms that regulate lung fluid balance and alveolar & pulmonary vascular development after premature birth.

  • Francis Blankenberg

    Francis Blankenberg

    Associate Professor of Radiology (Pediatric Radiology) and, by courtesy, of Pediatrics

    Current Research and Scholarly Interests Studies on apoptotic cell death in vivo using the H MRS phenomenon.

  • Rebecca Blankenburg, MD, MPH

    Rebecca Blankenburg, MD, MPH

    Clinical Professor, Pediatrics

    Current Research and Scholarly Interests My educational research interests focus on building a more diverse, inclusive and equitable learning environment and helping develop a sense of belonging, professional identity formation, and competence through longitudinal coaching and scholarly mentorship.

  • Terrence Blaschke

    Terrence Blaschke

    Professor of Medicine and of Molecular Pharmacology, Emeritus

    Current Research and Scholarly Interests Clinical pharmacology of antiretroviral drugs

    Pharmacokinetic and pharmacodynamic mechanisms of variability in drug response.

    Drug development

  • Helen M. Blau

    Helen M. Blau

    The Donald E. and Delia B. Baxter Foundation Professor, Director, Baxter Laboratory for Stem Cell Biology and Professor, by courtesy, of Psychiatry and Behavioral Sciences

    Current Research and Scholarly Interests Prof. Helen Blau's research area is regenerative medicine with a focus on stem cells. Her research on nuclear reprogramming and demonstrating the plasticity of cell fate using cell fusion is well known and her laboratory has also pioneered the design of biomaterials to mimic the in vivo microenvironment and direct stem cell fate. Current findings are leading to more efficient iPS generation, cell based therapies by dedifferentiation a la newts, and discovery of novel molecules and therapies.

  • Douglas W. Blayney

    Douglas W. Blayney

    Professor of Medicine (Oncology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Improving the quality of cancer care at Stanford, in our network of care, and nationally

  • Nikolas Blevins, MD

    Nikolas Blevins, MD

    Larry and Sharon Malcolmson Professor in the School of Medicine and Professor, by courtesy, of Neurosurgery at the Stanford University Medical Center

    Current Research and Scholarly Interests Inner ear microendoscopy -- Developing techniques for minimally-invasive imaging of inner ear microanatomy and neural pysiology. Applications include improved cochlear implant development, inner ear regenerative techniques, inner ear surgery, and auditory physiology.

    Microsurgical robotics -- Developing scalable microsurgical instrumentation and robotic techniques for use in head and neck surgery.

    Surgical Simulation -- Immersive environment for temporal bone surgical simulation.

  • Catherine Blish

    Catherine Blish

    Associate Professor of Medicine (Infectious Diseases)

    Current Research and Scholarly Interests The major goal of our research is to gain insight into the prevention and control of HIV and other viral pathogens by studying the interplay between the virus and the host immune response. We investigate the role of various arms of the immune response, but with a particular focus on NK cells. We hope to gain additional insights into control of infectious diseases by studying how pregnancy modulates immune responses.

  • Daniel Bloch

    Daniel Bloch

    Professor (Research) of Biomedical Data Science (BDS), Emeritus

    Bio I received my PhD. in Mathematical Statistics in 1967. I joined the research community at the Stanford University School of Medicine, Division of Immunology & Rheumatology, in 1984 as head statistician directing the biostatistics consulting and analytic support of the Arthritis Rheumatism Aging Medical Information System (ARAMIS) and Multipurpose Arthritis Center (MAC) grant-related research programs. In 1993 I was appointed Associate Professor with a joint appointment in the Departments of Medicine and of Health Research & Policy, and am currently Professor of Biostatistics at Stanford University, emeritus since 2007. My contributions to the statistics literature span numerous fields, including methods of sample size estimation, efficiency and bias of estimators, research methods for kappa statistics, non-parametric classification methods and methods of assessing multi-parameter endpoints. I have over 200 peer-reviewed publications. I have been directly involved with the development of numerous criteria rules for classification of diseases and with establishing guidelines for clinical trial research and in proposing responder criteria for osteoarthritis drugs. Since 1987, I have been a consultant on an ad hoc basis to pharmaceutical and biotechnical firms, including both start-up and established companies. I have extensive experience with devices, drugs and biologics and have participated in all aspects of applying statistics to implement investigational plans; e.g.: for protocol development, design of trials, database design. I?ve been a member of the FDA Statistical Advisors Panel, the statistical member on numerous data safety monitoring boards, and frequently represent companies at meetings with the FDA

  • Andra Leah Blomkalns

    Andra Leah Blomkalns

    Stanford Medicine Professor in Emergency Medicine and the Redlich Family Professor

    Current Research and Scholarly Interests Dr. Andra Blomkalns is an innovation advocate who believes the best patient-centered programs depend upon clinical practice innovation, continuous data-driven improvement, and interdisciplinary collaboration. Dr. Blomkalns has a long-standing history of scholarship and publication on cardiovascular emergencies, point-of-care testing, innate immunity, and obesity. She has authored or contributed to more than 14 chapters and more than 40 journal articles in peer-reviewed publications on topics influential to administration and organization, clinical best practices, and scientific exploration. Additionally, her grant portfolio diversity reflects her multi-pronged, collaborative approach, and includes institutional, investigator-initiated industry, and federal funding.

  • Gordon Bloom

    Gordon Bloom

    Lecturer, Medicine - Primary Care and Population Health

    Bio Gordon founded the Social Entrepreneurship Collaboratory (SE Labs) at Stanford, Harvard and Princeton. He teaches about the design, development and leadership of innovative social ventures in global health and environmental sustainability.

    At Stanford, Gordon is director of the Social Entrepreneurship and Innovation Lab (SE Lab)- Human & Planetary Health and is a faculty fellow of the Center for Innovation in Global Health. He is a Lecturer in the School of Medicine, Division of Primary Care and Population Health/Dept. of Medicine, an affiliate at the Center for Health Policy and the Center for Primary Care and Outcomes Research, Freeman Spogli Institute for International Studies, and a mentor in the Knight-Hennessy Scholars Program.

    At Harvard, Gordon taught jointly on the faculties of the Harvard T. H. Chan School of Public Health (Health Policy & Management) and the Harvard Kennedy School (Management, Leadership & Decision Sciences) and served as an Expert-in-Residence (EiR) at the Harvard Innovation Lab (i-Lab), and affiliated faculty at the Center for Primary Care, Harvard Medical School (HMS). He was faculty director of the Social Entrepreneurship and Innovation Lab (SE Lab) for US & Global Health, an incubator course taught in a new interdisciplinary, collaborative model based at the i-Lab. He has also served as an Entrepreneur-in-Residence (2013-2014) at Harvard Business School in the Rock Center for Entrepreneurship, on the Faculty of Arts & Sciences in the Sociology Department, at the Harvard Kennedy School, on the Leadership & Management faculty, and as a principal of the Hauser Center for Non-Profit Organizations (2004-2007). Gordon served as one of the founding faculty of the $10 million Reynolds Fellows Program in Social Entrepreneurship, a Center for Public Leadership and Harvard President?s interdisciplinary fellowship initiative that paid full tuition and stipend for graduate students from the Harvard Kennedy School, School of Public Health and Graduate School of Education.

    At Princeton, Gordon served as Dean?s Visiting Professor in Entrepreneurship in 2009-2010. Working together with the School of Engineering & Applied Science, the Woodrow Wilson School of Public & International Affairs, and the Faculty of Arts & Sciences, he launched a new set of programs and prizes in social innovation and entrepreneurship in collaboration with students, faculty and alumni.

    At Stanford in 2001-2002, Gordon created the SE Lab, a Silicon Valley and technology?influenced, interdisciplinary incubator for social ventures and global problem solving. Gordon taught on the Public Policy Program and Urban Studies faculties (School of Humanities & Sciences) and served as a faculty affiliate at the Center for Social Innovation at Stanford Graduate School of Business, and a Program Officer at Stanford?s Freeman Spogli Institute for International Studies.

    Many of the talented students and fellows in Gordon?s SE Labs have won the top awards of prestigious idea and business plan competitions, including those at Stanford, Harvard, Princeton and MIT.

    Gordon is an author in the edited volume Social Entrepreneurship: New Models of Sustainable Social Change (A. Nicholls, ed., Yunus, Drayton et. al., Oxford University Press, 2006/2008) and served as a founding member of the Oxford/Ashoka led University Network for Social Entrepreneurship. His interest in entrepreneurship is informed by work in both the private and nonprofit sectors in the U.S. (New York, Cambridge, Palo Alto), Europe (London, Paris) and Asia (Hong Kong), as CEO of a medical technology company and in international strategy consulting.

    Gordon is married to Sara Singer- they on occasion teach together at Stanford, have a daughter Audrey (21) and son Jason (17), and live in the residential section of campus.

  • Thomas Jefferson Blumenfeld

    Thomas Jefferson Blumenfeld

    Clinical Associate Professor, Orthopaedic Surgery

    Bio Dr. Blumenfeld is a board-certified, fellowship-trained orthopaedic surgeon with a clinical focus on primary and revision hip and knee joint replacement surgery. He is a clinical associate professor of orthopaedic surgery at Stanford University School of Medicine.

    Dr. Blumenfeld has performed more than 4,000 knee and hip replacement procedures. His expert technique, comprehensive experience, and careful attention to detail enable him to excel at both first-time and revision procedures. Over the course of his career, he has achieved and maintained a complication rate well below the national average.

    He listens empathetically to all patients, seeking to understand the impact their condition has on their daily activities. He prepares a personalized treatment plan that corresponds to the needs of each patient.

    In every case, Dr. Blumenfeld?s treatment goals are to help relieve pain, enhance function, and improve quality of life. He seeks to assure even firsttime patients that he is committed to helping them fully understand both their diagnosis and recommended treatment, as well as timeframe for recovery.

    All patients follow-up at regular intervals for clinical and X-ray evaluations following surgery. Dr. Blumenfeld encourages patients to visit him at least once every two years for a preventive care evaluation.

    In addition to delivering clinical care, Dr. Blumenfeld conducts extensive research. He has been a principal investigator on clinical trials of new hip replacement systems. He was also a clinical investigator testing a robotic surgical system for total hip arthroplasty procedures. The team that developed this breakthrough received the prestigious Computerworld Smithsonian Award for Innovation in the Arts and Sciences for Medicine. As a pioneer in robotic surgery, Dr. Blumenfeld selectively uses computer-aided navigation technology for planning and performing surgical procedures.

    Most recently, Dr. Blumenfeld?s research has focused on how to help surgeons reduce complication rates. He is actively investigating how the long termcost of hip and knee replacement procedures may vary depending on how early a patient¬ is diagnosed and treated.

    He has authored dozens of articles on advanced surgical techniques for hip and knee arthroplasty, new materials for surgical implants, prevention of surgery-related infection, and other topics. His work has appeared in publications including Clinical Orthopaedics and Related Research, Journal of Arthroplasty, the Journal of Bone and Joint Surgery, Hip International, and others. In addition to authoring book chapters on primary and revision hip replacement surgery, Dr. Blumenfeld has written a book that shares his perspective on managed care and physician-patient communication.

    He serves on the editorial boards of the Journal of Arthroplasty, Arthroplasty Today, and Clinical Orthopaedics and Related Research and is CME editor for Arthroplasty Today. He has been a member of the Adult Reconstruction?Knee Program Subcommittee and Hip Program Subcommittee for the Annual Meeting of the American Academy of Orthopedic Surgeons.

    Dr. Blumenfeld has given presentations on advances in joint replacement surgery at the American Association of Hip and Knee Surgeons Annual Meeting, American Academy of Orthopedic Surgeons Annual Meeting, and other conferences.

  • Yair Blumenfeld

    Yair Blumenfeld

    Associate Professor of Obstetrics and Gynecology (Maternal Fetal Medicine) at the Stanford University Medical Center

    Current Research and Scholarly Interests prenatal diagnosis, genetics, clinical obstetrics

  • Mark S. Blumenkranz, MD, MMS

    Mark S. Blumenkranz, MD, MMS

    H. J. Smead Professor of Ophthalmology, Emeritus

    Current Research and Scholarly Interests Clinical Interest and Research
    My primary areas of interest are in the diagnosis, medical and surgical treatment of vitreal retinal diseases. These principally include age-related macular degeneration and other diseases of the macula, and tractional syndromes, diabetic retinopathy, and complex forms of retinal detachment. I have been interested in the development of novel technology to diagnose and treat these diseases, including new forms of imaging, laser delivery systems, other microsurgical tools, and new drugs and drug delivery systems that inhibit new blood vessel growth, scarring and intraocular inflammation. I have been actively involved in translational research in the laboratory as well as technology transfer associated with that research for a variety of new therapies that have received FDA clearance and been introduced into clinical practice over the past 30 years.

    Administrative and Community Service
    I have served on the Board of Directors of a variety of voluntary education and service organizations, including the Corporation of Brown University, multiple scientific advisory boards and various philanthropic and research organizations.

  • Paul D. Blumenthal, MD, MPH

    Paul D. Blumenthal, MD, MPH

    Professor of Obstetrics and Gynecology (Gynecology-Family Planning) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests Improving Access to Family Planning Services in Low Resource Settings:

    Through a collaboration with Population Services International, the Stanford Program for International Reproductive Education and Services (SPIRES) provides technical direction in a program designed to improve access to and uptake of family planning, particularly Long Acting Reversible Contraception (LARC) such as IUDs and implants, in 14 developing countries globally. The first year saw insertion of over 280,000 IUDs.

  • Adjoa Boateng

    Adjoa Boateng

    Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

    Bio Adjoa Boateng is a physician, writer, purveyor of the arts and humanitarian. She completed her undergraduate degree and anesthesiology training at Yale, then undertaking a critical care fellowship at Stanford. Prior to her role as an anesthesiologist and critical care physician, Adjoa completed work in several facets of addiction medicine performing clinical research at the Mount Sinai Hospital in New York City, undertaking projects focusing on Hepatitis C in injection drug users, during her MPH degree she analyzed programs in Philadelphia which trained heroin users to inject Naloxone to mitigate overdose, and in medical school was selected among many to complete a prestigious training course at the renowned Betty Ford Center in Rancho Mirage, California, always seeking to assist the forgotten; those at the margins of society. Adjoa marries this to her current areas of interest, which include the intersection of medicine, the arts and the disadvantaged. She currently is investigating racial and ethnic disparities in critical care medicine.

  • Alexandria Boehm

    Alexandria Boehm

    Professor of Civil and Environmental Engineering and Senior Fellow at the Woods Institute for the Environment

    Bio I am interested in pathogens in the environment including their sources, fate, and transport in natural and engineered systems. I am interested in understanding of how pathogens are transmitted to humans through contact with water, feces, and contaminated surfaces. My research is focused on key problems in both developed and developing countries with the overarching goal of designing and testing novel interventions and technologies for reducing the burden of disease.

    I am also interested broadly in coastal water quality where my work addresses the sources, transformation, transport, and ecology of biocolloids - specifically fecal indicator organisms, DNA, pathogens, and phytoplankton - as well as sources and fate of nitrogen. This knowledge is crucial to formulating new management policies and engineering practices that protect human and ecosystem health at the coastal margins.

  • Alistair Boettiger

    Alistair Boettiger

    Assistant Professor of Developmental Biology

    Current Research and Scholarly Interests My lab focuses on investigating the role of three-dimensional genome organization in regulating gene expression and in shaping cell fate specification during development. We pursue this with advanced single-molecule imaging and transgenics.

  • Matthew Bogyo

    Matthew Bogyo

    Professor of Pathology and of Microbiology and Immunology and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly Interests Our lab uses chemical, biochemical, and cell biological methods to study protease function in human disease. Projects include:

    1) Design and synthesis of novel chemical probes for serine and cysteine hydrolases.

    2) Understanding the role of hydrolases in bacterial pathogenesis and the human parasites, Plasmodium falciparum and Toxoplasma gondii.

    3) Defining the specific functional roles of proteases during the process of tumorogenesis.

    4) In vivo imaging of protease activity

  • Bryan Bohman

    Bryan Bohman

    Clinical Professor, Anesthesiology, Perioperative and Pain Medicine

    Bio Bryan Bohman is Chief Medical Officer for University HealthCare Alliance (UHA), Stanford?s community-based medical foundation. He also serves as Associate Chief Medical Officer at Stanford Health Care (SHC). At the School of Medicine, his roles include Associate Dean for Stanford Medicine Partners, Clinical Professor of Anesthesiology, Perioperative and Pain Medicine, Co-Director of the Clinical Effectiveness Leadership Training (CELT) program and Senior Advisor to the WellMD Center.

    Dr. Bohman trained at Stanford in internal medicine and anesthesiology. After two decades of clinical practice in community-based anesthesiology, he served as SHC Chief of Staff from 2008-2011.

    As Chief of Staff, Dr. Bohman founded Stanford?s wellness committee and subsequently shepherded the founding of its WellMD Center in 2015, serving as the Center?s interim Director until 2017. The Center?s aim is to advance faculty, trainee and care team wellbeing across Stanford Medicine while also serving as an international leader of scholarship in a field that is increasingly vital to the future of medicine.

    Dr. Bohman?s primary areas of interest include population health management and the relationships between clinician wellness, quality improvement and healthcare system performance.

  • Cara Bohon

    Cara Bohon

    Assistant Professor of Psychiatry and Behavioral Sciences (Child and Adolescent Psychiatry and Development) at the Stanford University Medical Center

    Current Research and Scholarly Interests My research interests have focused on the neural bases of eating disorders. I am particularly interested in the way emotion and reward is processed in the brain and how that may contribute to eating behavior and food restriction. I hope to eventually translate biological research findings into treatments.

Footer Links:

Stanford Medicine Resources: